GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Functional Defecation Disorders
Functional GI

Functional Defecation Disorders

Rome IV — dyssynergia and inadequate propulsion

Prerequisite

A prerequisite, not an alternative. A functional defecation disorder is diagnosed on top of one of those, never instead of it.

Objective evidence — two of three required

Subtyping on manometry

Inadequate propulsion gives F3a; adequate propulsion with inappropriate pelvic floor contraction gives F3b, dyssynergic defecation. Both are defined against age- and sex-appropriate normal values.

Requires functional constipation and/or IBS-C to be present first, then two of three objective tests showing impaired evacuation. This is the diagnosis missed in refractory constipation, because laxatives do not fix a coordination problem.

When to use
Use it in a constipated patient who is not responding to laxatives, particularly one who describes straining, incomplete evacuation, or needing to splint or digitate. Those symptoms are the trigger for testing rather than the diagnosis itself. Because the criteria require physiological testing, this diagnosis is made in a service with access to anorectal manometry and balloon expulsion — but the decision to refer is made in general clinic, and it is that referral, not the testing, that is most often missed.
Why use it
Because it identifies the constipated patients for whom laxatives are the wrong treatment. A patient who cannot coordinate evacuation does not have a transit problem, and adding osmotic or stimulant laxatives to a functional outlet obstruction produces urgency and discomfort without resolving the difficulty. What works is biofeedback, which retrains the coordination of abdominal push and pelvic floor relaxation, and which has randomised evidence of superiority over laxatives in exactly this group. A substantial minority of patients referred for refractory constipation have a defecation disorder, and they will continue to fail escalating laxative regimens indefinitely until someone tests them.
Formula, evidence and interpretation

About the Rome IV Criteria for Functional Defecation Disorders

The only Rome IV diagnosis in this chapter that requires objective testing rather than symptoms alone. Two things must be true. First, the patient must satisfy the criteria for functional constipation and/or for irritable bowel syndrome with constipation — this is a diagnosis layered on top of another, not an alternative to it. Second, there must be evidence of impaired evacuation on at least two of three tests: an abnormal balloon expulsion test, abnormal anorectal manometry or anal surface EMG, and abnormal rectal evacuation on imaging. Meeting both then subclassifies into inadequate defecatory propulsion or dyssynergic defecation depending on whether the propulsive force is insufficient or the pelvic floor fails to relax.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Functional defecation disorder = (meets functional constipation criteria OR meets IBS-C criteria) AND ≥ 2 of 3 abnormal: • balloon expulsion test • anorectal manometry or anal surface EMG • rectal evacuation imaging Subtype: inadequate propulsive forces → F3a inadequate defecatory propulsion inappropriate contraction or < 20% relaxation of basal resting sphincter pressure, with adequate propulsive forces → F3b dyssynergic defecation
Two of three tests
Not one. Rome IV requires corroboration because each individual test has meaningful false-positive and false-negative rates, particularly in the artificial setting of a laboratory.
20% relaxation
The manometric threshold in dyssynergic defecation — less than 20% relaxation of basal resting sphincter pressure counts as abnormal, alongside frank paradoxical contraction.
Adequate propulsive forces
The feature that assigns a patient to dyssynergia rather than inadequate propulsion. Where propulsion is insufficient, the diagnosis is F3a regardless of what the sphincter does.
  • This is the only Rome IV disorder in the anorectal chapter that requires objective testing — the rest are symptom-defined.
  • The underlying diagnosis is a prerequisite, not an alternative: functional constipation or IBS-C must be met first.
  • The 'two of three' rule exists because attempting defecation on a laboratory couch is unnatural and produces abnormal results in some healthy people.
  • Straining, incomplete evacuation and digitation are what prompt testing; they are not themselves diagnostic criteria.

Interpreting the result

A positive result should redirect treatment rather than add to it. Biofeedback is the intervention with randomised evidence of benefit — it retrains the coordination of abdominal push and pelvic floor relaxation, and trials have shown it superior to laxatives, to sham feedback and to diazepam in dyssynergic defecation, with durable effect. It is not a course of exercises to do unsupervised; the benefit comes from instrumented feedback with a trained therapist, which is why access to a service matters. Laxatives may still be needed for stool consistency but should not be escalated in the expectation of resolving the outlet problem. Where testing is equivocal — one abnormal test out of three — the diagnosis is not met, and it is reasonable either to repeat testing or to trial biofeedback pragmatically in a patient whose symptoms fit strongly, while remaining clear that the criteria have not been satisfied. Where evacuation is impaired and there is also incontinence, treat the evacuation disorder first, since chronic impaction with overflow frequently resolves when the outlet problem is addressed.

ScoreBandWhat it meansAction
F3a — Inadequate defecatory propulsionInsufficient propulsive forceUnderlying constipation criteria met plus 2 of 3 abnormal tests, with inadequate propulsionBiofeedback with emphasis on generating effective abdominal propulsive pressure
F3b — Dyssynergic defecationAdequate push, outlet fails to openInappropriate pelvic floor contraction or < 20% relaxation of basal resting sphincter pressure, with adequate propulsionBiofeedback with emphasis on pelvic floor relaxation — randomised evidence of superiority over laxatives
Criteria not metThreshold not reachedUnderlying criteria not met, or fewer than two abnormal testsManage as functional constipation or IBS-C; consider repeat testing if symptoms strongly suggest an outlet problem

What the Functional Defecation Disorders needs (6 inputs)

Patient meets criteria for functional constipation and/or IBS with constipation
Mandatory. Rome IV builds this diagnosis on top of an existing one — a patient who does not meet either underlying set of criteria cannot have a functional defecation disorder.
Abnormal balloon expulsion test
One of the three objective tests. Inability to expel a filled balloon within a defined time is the simplest and most accessible screen for impaired evacuation.
Abnormal anorectal manometry or anal surface EMG
Demonstrates the pattern during attempted defecation — insufficient propulsive pressure, or failure of anal relaxation or paradoxical contraction.
Abnormal rectal evacuation on imaging
Barium or MR defaecography showing impaired evacuation of rectal contents.
Subclassification — propulsive force
Inadequate defecatory propulsion (F3a) is defined by insufficient propulsive forces, with or without inappropriate anal contraction or inadequate relaxation.
Subclassification — pelvic floor behaviour
Dyssynergic defecation (F3b) is defined by inappropriate contraction of the pelvic floor, or by less than 20% relaxation of basal resting sphincter pressure, with adequate propulsive forces.

What it returns

Whether the diagnostic threshold is met
Underlying functional constipation or IBS-C, plus two or more abnormal tests of the three.
Subtype
Inadequate defecatory propulsion or dyssynergic defecation — distinguished by whether propulsive force is adequate.
Whether biofeedback is indicated
Both subtypes are biofeedback candidates, though the retraining emphasis differs.

How it is calculated

Normal defecation requires two things to happen at once: the abdominal muscles and diaphragm generate propulsive pressure, and the pelvic floor and anal sphincter relax to let stool pass. A functional defecation disorder is a failure of that coordination, and Rome IV separates the two ways it fails. In inadequate defecatory propulsion the push is insufficient, whatever the sphincter does. In dyssynergic defecation the push is adequate but the outlet does not open — the pelvic floor contracts paradoxically or relaxes by less than 20% of basal resting pressure. Either way the result is a functional obstruction that behaves nothing like slow transit, which is why laxatives disappoint. The insistence on two abnormal tests reflects a practical problem: defecating on demand, on a couch, with a catheter in place, is not a natural act, and a proportion of asymptomatic people produce abnormal results under those conditions. Requiring corroboration across two modalities reduces the chance of labelling a testing artefact as disease.

Facts & figures

The three tests and what each contributes
TestWhat it showsPractical notes
Balloon expulsionWhether a filled balloon can be expelled in a defined timeSimplest and most accessible; good screening test but not sufficient alone
Anorectal manometry / anal surface EMGPropulsive pressure and whether the sphincter relaxes on attempted defecationProvides the < 20% relaxation threshold and separates the two subtypes
Rectal evacuation imagingWhether rectal contents actually leaveBarium or MR defaecography; also identifies structural contributors such as rectocele or intussusception

Two of the three must be abnormal. No single test is sufficient, because attempted defecation in a laboratory setting produces abnormal results in some healthy people.

Distinguishing the two subtypes
FeatureInadequate propulsion (F3a)Dyssynergic defecation (F3b)
Propulsive forceInsufficientAdequate
Sphincter behaviourMay or may not contract inappropriatelyInappropriate contraction, or < 20% relaxation of basal resting pressure
Biofeedback emphasisGenerating effective abdominal pushRelaxing the pelvic floor during push
Underlying diagnosis requiredFunctional constipation and/or IBS-CFunctional constipation and/or IBS-C

Adequacy of propulsive force is the deciding feature — where it is insufficient, the diagnosis is F3a regardless of sphincter behaviour.

Evidence

Derivation — Rome Foundation, anorectal disorders committee

2016

Consensus criteria from the Rome IV anorectal disorders committee, published in Gastroenterology in 2016.

Rome IV retained the requirement for objective testing and strengthened it to two of three abnormal tests, reflecting the recognised false-positive rate of any single test performed in a laboratory setting.

Randomised trial — biofeedback versus laxatives

2006

Randomised trial of biofeedback compared with polyethylene glycol in patients with dyssynergic defecation, reported by Chiarioni and colleagues in 2006.

Biofeedback was substantially superior to laxative therapy, with the advantage sustained at long-term follow-up — the core evidence for treating this group differently from other constipated patients.

Randomised trial — biofeedback versus sham and diazepam

2007

Randomised controlled trial of manometric biofeedback against sham feedback and against diazepam in dyssynergic defecation, reported by Rao and colleagues in 2007.

Biofeedback outperformed both comparators, establishing that the benefit is not attributable to attention or to non-specific muscle relaxation.

Guideline adoption — ACG 2021

2021

ACG clinical guideline on the management of benign anorectal disorders.

Recommends anorectal testing in constipated patients not responding to conservative therapy, and biofeedback as the treatment of choice where a defecation disorder is confirmed.

How it compares

Functional Defecation Disorders vs Functional constipation

One is the prerequisite for the other — and the reason to test is that the treatments diverge completely.

Functional constipation is symptom-defined and needs no testing. A functional defecation disorder requires those criteria to be met and then adds objective evidence of impaired evacuation on two of three tests. The clinical importance of separating them is that the treatments are different: functional constipation without an outlet problem responds to laxatives and dietary measures, while a defecation disorder responds to biofeedback and continues to fail escalating laxatives. A patient labelled refractory after several laxative failures should be tested rather than given a fourth agent.

Open the Functional constipation calculator →

Functional Defecation Disorders vs Rome IV IBS

IBS with constipation is an equally valid entry point — the defecation disorder can sit on top of either.

Rome IV explicitly permits the underlying diagnosis to be functional constipation or IBS with constipation, recognising that the two overlap heavily and that the presence of pain does not exclude an outlet problem. A patient with IBS-C who strains, digitates and fails laxatives deserves anorectal testing just as much as one labelled with functional constipation. Missing this is a common route to prolonged unsuccessful treatment, because the IBS label tends to close down further physiological assessment.

Open the Rome IV IBS calculator →

Functional Defecation Disorders vs Faecal incontinence

Opposite symptoms that frequently coexist — and the evacuation disorder should be treated first.

Impaired evacuation leads to chronic retention, and retention leads to leakage of liquid stool around impacted material. A patient can therefore meet criteria for both, and treating the incontinence with antidiarrhoeals makes matters worse. Both are assessed with anorectal manometry and both are treated with biofeedback, but the retraining targets differ, and resolving the outlet obstruction commonly resolves the leakage without any separate intervention.

Open the Faecal incontinence calculator →Wald A, Bharucha AE, Limketkai B, et al. ACG Clinical Guidelines: Management of Benign Anorectal Disorders. Am J Gastroenterol. 2021;116(10):1987-2008.

Pearls & pitfalls

  • This diagnosis sits on top of another — functional constipation or IBS-C must be met first, not instead.
  • Two of three tests must be abnormal. A single abnormal balloon expulsion does not make the diagnosis.
  • Straining, incomplete evacuation, splinting and digitation are the reason to test, not the criteria themselves.
  • Laxatives do not fix an outlet problem. Escalating them in a patient with dyssynergia produces urgency without resolution.
  • Biofeedback is instrumented retraining with a therapist, not unsupervised exercises — the evidence applies to the former.
  • Adequacy of propulsive force is what separates the subtypes; where it is insufficient, the diagnosis is F3a whatever the sphincter does.
  • Less than 20% relaxation of basal resting sphincter pressure counts as abnormal, alongside frank paradoxical contraction.
  • A meaningful proportion of asymptomatic people fail single tests, which is exactly why corroboration is required.
  • Where evacuation disorder and incontinence coexist, treat the evacuation problem first — overflow often resolves with it.
  • Defaecography can also reveal rectocele or intussusception, which changes management independently of the Rome criteria.

Critical actions

  • Confirm the patient meets functional constipation or IBS-C criteria before pursuing this diagnosis.
  • Ask specifically about straining, sensation of incomplete evacuation, and the need to splint the perineum or digitate.
  • Perform a digital rectal examination and observe the response to a simulated push — paradoxical contraction is often detectable at the bedside.
  • Refer for anorectal physiology in constipated patients not responding to conservative measures rather than escalating laxatives indefinitely.
  • Obtain at least two of the three tests, since one abnormal result does not meet the criteria.
  • Record the subtype, since the biofeedback emphasis differs between inadequate propulsion and dyssynergia.
  • Refer to a service that provides instrumented biofeedback with a trained therapist.
  • Continue attention to stool consistency alongside biofeedback rather than stopping laxatives abruptly.
  • Reconsider structural contributors on imaging — rectocele, intussusception — which may need separate management.

Why this score exists

The 'two of three' rule is the interesting decision here, and it is an admission against interest. Rome IV could have accepted a single abnormal test, which would have made the diagnosis far easier to reach and would have expanded the group offered an effective treatment. It did not, because the committee knew what the tests actually measure: a person asked to defecate on a couch, in a clinic, with a catheter in place and someone watching, is not doing the thing the test claims to assess. A meaningful proportion of asymptomatic volunteers fail balloon expulsion or show paradoxical contraction under those conditions. Requiring two independent modalities to agree is a way of demanding that the abnormality survive a change of setting and technique. It makes the criteria harder to satisfy and the diagnosis more trustworthy — which is the right trade when the alternative is committing patients to a course of instrumented retraining for an artefact.

About the creator

  • Satish S. C. Rao

    First author, Rome IV anorectal disorders committee; led the randomised biofeedback trial

    Both chaired the criteria committee and produced much of the trial evidence underpinning biofeedback in dyssynergic defecation.

  • Giuseppe Chiarioni

    Co-author; lead author of the biofeedback versus laxative trial

    His 2006 trial established biofeedback as superior to laxatives in this group.

  • Adil E. Bharucha

    Co-author; anorectal physiology

    Contributed substantially to the physiological testing standards the criteria depend on.

Limitations

  • Requires physiological testing that is not available in every centre, which limits where the diagnosis can be made at all.
  • Each individual test has appreciable false-positive rates in asymptomatic people, which the two-of-three rule mitigates but does not eliminate.
  • Attempting defecation in a laboratory setting is unnatural and may not reflect what happens at home.
  • Patients with one abnormal test and strongly suggestive symptoms fall outside the criteria despite often responding to biofeedback.
  • Manometric normal ranges vary between systems and protocols, so thresholds are not perfectly transferable.
  • The criteria do not address structural findings such as rectocele or intussusception, which may coexist and need separate management.
  • Consensus-derived, with no measured sensitivity or specificity against a clinical outcome standard.
  • Access to instrumented biofeedback with a trained therapist is the practical limiting factor even when the diagnosis is made correctly.

If you are the patient

Opening the bowels normally needs two things to happen together: pushing down with the tummy muscles, and letting the muscles around the back passage relax so stool can pass. In some people that coordination goes wrong — either the push is not strong enough, or the muscles tighten instead of relaxing. The result feels like constipation, but it is really a problem at the exit rather than in the bowel itself, and that matters because laxatives do not fix it. Common experiences include straining a lot, feeling that you have not finished even after going, and sometimes needing to press around the area to help. To confirm it, a specialist does tests measuring the pressures in the back passage and checking whether you can push out a small balloon. Two tests need to agree before the diagnosis is made — deliberately, because doing this on a clinic couch is not natural and one odd result on its own is not reliable enough. The treatment that works is biofeedback: sessions with a therapist using sensors that show you what your muscles are doing, so you can learn to push and relax at the same time. It sounds simple but it works well, and studies have shown it beats laxatives clearly in this group. It is not the same as doing pelvic floor exercises at home — the feedback from the sensors is what makes the difference.

Frequently asked questions

What are the Rome IV criteria for functional defecation disorders?#

The patient must first meet criteria for functional constipation and/or IBS with constipation, and must then show evidence of impaired evacuation on at least two of three tests: balloon expulsion, anorectal manometry or anal surface EMG, and rectal evacuation imaging. Meeting both parts allows subclassification into inadequate defecatory propulsion or dyssynergic defecation.

Why are two abnormal tests required rather than one?#

Because attempting to defecate on a clinic couch with a catheter in place is not a natural act, and a meaningful proportion of asymptomatic people produce abnormal results under those conditions. Requiring two independent modalities to agree means the abnormality has survived a change of setting and technique, which makes the diagnosis considerably more trustworthy.

What is the difference between inadequate propulsion and dyssynergic defecation?#

Whether the push is adequate. In inadequate defecatory propulsion the propulsive force is insufficient, with or without abnormal sphincter behaviour. In dyssynergic defecation the propulsive force is adequate but the outlet fails to open — the pelvic floor contracts inappropriately or relaxes by less than 20% of basal resting sphincter pressure.

Can a patient with IBS have a functional defecation disorder?#

Yes — Rome IV explicitly allows IBS with constipation as the underlying diagnosis alongside functional constipation. A patient with IBS-C who strains, digitates and fails laxatives warrants anorectal testing. Missing this is a common cause of prolonged unsuccessful treatment, because the IBS label often stops further physiological assessment.

What treatment works?#

Biofeedback. Randomised trials have shown it superior to polyethylene glycol, to sham feedback and to diazepam in dyssynergic defecation, with durable benefit. It is instrumented retraining conducted with a therapist rather than unsupervised exercises, and the evidence applies specifically to the supervised form.

Why do laxatives not work?#

Because the problem is at the outlet, not in transit. Adding osmotic or stimulant laxatives to a functional obstruction increases urgency and discomfort without addressing the coordination failure that prevents evacuation. Laxatives may still be useful for stool consistency, but escalating them in the expectation of resolving the difficulty is what keeps these patients labelled refractory.

What symptoms should prompt testing?#

Straining, a sensation of incomplete evacuation, and the need to splint the perineum or digitate — particularly in a patient who has failed conservative measures. These are the reason to refer for anorectal physiology; they are not themselves diagnostic criteria, which is why the diagnosis cannot be made on history alone.

What if only one of the three tests is abnormal?#

The criteria are not met. It is reasonable either to repeat testing or, in a patient whose symptoms fit strongly, to trial biofeedback pragmatically — but the diagnosis should not be recorded as established. Being explicit about this matters when interpreting studies, since trial populations are defined by the full criteria.

Related calculators

  • Functional Constipation — Rome IV — two of six items, IBS excluded
  • Faecal Incontinence (Rome IV) — Rome IV — the criteria, and why nobody is asked
  • Functional Anorectal Pain — Levator ani, unspecified pain and proctalgia fugax
  • Rome IV Criteria for IBS — Irritable bowel syndrome diagnosis and subtype
  • Bristol Stool Scale — Stool form types 1–7 and colonic transit

References

Original / primary reference

  1. Rao SSC, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, Wald A. Anorectal Disorders. Gastroenterology. 2016;150(6):1430-1442 (Rome IV).

Validation and treatment evidence

  1. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657-664.
  2. Rao SSC, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5(3):331-338.

Clinical practice guidelines

  1. Wald A, Bharucha AE, Limketkai B, Malcolm A, Remes-Troche JM, Whitehead WE, Rao SSC. ACG Clinical Guidelines: Management of Benign Anorectal Disorders. Am J Gastroenterol. 2021;116(10):1987-2008.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.